Hyperfine (HYPR) Investor presentation summary

Market opportunity and product positioning

• Portable, AI-powered MRI system addresses limited access and high costs of traditional MRI, enabling imaging at multiple care sites without specialized infrastructure or personnel.

• US total addressable market projected to grow from $1.5B in inpatient settings to $16B in community settings by 2026, with expansion into emergency departments, neurology clinics, urgent care, and nursing homes.

• Swoop system's portability and ease of use improve MRI capacity, access, and efficiency, delivering clinical and economic benefits across care settings.

Technology and clinical validation

• Next Gen Swoop system, powered by Optive AI, delivers image quality approaching conventional MRI, supporting confident diagnoses at the point of care.

• AI-driven software reduces noise and blur, enhances clarity, and is available on all Swoop systems, with 11 generations of AI-enabled software and multiple FDA clearances.

• Over 80 peer-reviewed publications and 215+ conference presentations validate broad clinical utility across key sites and use cases.

Commercial growth and strategy

• Over 200 Swoop systems installed globally, with direct sales in the US and distributors in 10+ international markets.

• Majority of US sales now with Next Gen Swoop system, realizing higher pricing and multi-system placements in hospitals.

• Commercial expansion targets hospitals, offices, and international markets, with reimbursement in place under existing CPT codes.